Parkinson’s disease (PD) is the second most common neurodegenerative disease. Currently approximately one million people in the U.S and more than 10 million people worldwide are living with PD. Lewy bodies are the pathologic hallmark of PD. The protein α-synuclein has been identified as the major component of Lewy bodies and Lewy neurites. Chapter 1 provides an introduction to α-synuclein, from the widely believed intrinsically disordered monomer narrative to increasing recent evidence on α-synuclein adopting a stable multimeric (primarily tetrameric) form in solution. We believe that the means by which heterologously expressed α-synuclein was purified likely disrupts the tetrameric form and contributed to the intrinsically disordered monomer narrative. Inspired by the tetrameric domain of the Nipah virus RNA phosphoprotein, site directed mutagenesis was used to mutate valines to leucines in selected position (V52/55L, V74/77L, V52/55/74/77L) within the hydrophobic core of the tetramerization domain, to encourage the formation of leucine zippers in the hope of achieving a crystallization stable dynamic tetrameric structure. The purified mutant proteins were characterized using native gel and size exclusion chromatography. Subsequently, analysis on how buffer conditions were to affect leucine mutants using ThermoFluor aggregation assays were performed to find possible crystallization conditions. Lastly, Chapter I describes crystallography efforts and mutant NMR backbone assignments with suggestions for future research directions on this project.
A participant in the methionine salvage pathway, acireductone dioxygenase (ARD) has two isozyme forms that perform different chemistry depending on its incorporated metal center at the active site. Such dual chemistry has been observed in both bacterial and mammalian systems. Chapter II describes the solution structural NMR characterization of the Fe2+-bound human acireductone dioxygenase (HsARD) along with the interaction of HsARD with the regulatory tail of membrane type-1 matrix metalloproteinase (MT1-MMP) as measured by fluorescence polarization (FP) titration assay, isothermal calorimetry (ITC) and NMR. The Fe2+-bound HsARD NMR structure were compared to the Ni2+ -bound HsARD NMR structure to highlight the consistency in structure to perform dual chemistry observed in other bacterial and mammalian systems. Discussions on how the last 20 residues on MT1-MMP were to interact with both Fe2+- bound HsARD and Ni2+ -bound HsARD raises questions for further investigation.
|Advisor:||Pochapsky, Thomas C.|
|Commitee:||Pandelia, Maria-Eirini, Ringe, Dagmar|
|School Location:||United States -- Massachusetts|
|Source:||DAI-B 82/3(E), Dissertation Abstracts International|
|Subjects:||Biochemistry, Chemistry, Biophysics|
|Keywords:||Acireductone dioxygenase, Crystallography, NMR, Parkinson’s disease, Type-1 matrix metalloproteinase, α-synuclein|
Copyright in each Dissertation and Thesis is retained by the author. All Rights Reserved
The supplemental file or files you are about to download were provided to ProQuest by the author as part of a
dissertation or thesis. The supplemental files are provided "AS IS" without warranty. ProQuest is not responsible for the
content, format or impact on the supplemental file(s) on our system. in some cases, the file type may be unknown or
may be a .exe file. We recommend caution as you open such files.
Copyright of the original materials contained in the supplemental file is retained by the author and your access to the
supplemental files is subject to the ProQuest Terms and Conditions of use.
Depending on the size of the file(s) you are downloading, the system may take some time to download them. Please be